Literature DB >> 18544675

Peter B. Dews and pharmacological studies on behavior.

James E Barrett1, Jack Bergman.   

Abstract

The publications by Peter B. Dews of a series of five articles entitled "Studies on Behavior", beginning in 1955 and ending in 1959, were contributions of extraordinary significance in laying a foundation for the emergence of the discipline of behavioral pharmacology. The series of articles were rigorous in their approach, dramatic in terms of the results, and provocative in their implications. Published at the near half-century mark of the founding of the American Society for Pharmacological and Experimental Therapeutics, it is appropriate to now provide a Centennial Perspective on the impact of these studies over 50 years following their publication and to comment on the way in which they helped to influence the directions in which this discipline has evolved.

Mesh:

Year:  2008        PMID: 18544675     DOI: 10.1124/jpet.108.139261

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

Review 1.  The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond.

Authors:  John D Salamone; Merce Correa; Eric J Nunes; Patrick A Randall; Marta Pardo
Journal:  J Exp Anal Behav       Date:  2012-01       Impact factor: 2.468

2.  Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors.

Authors:  Ming Li; Tao Sun; Alexa Mead
Journal:  J Neural Transm (Vienna)       Date:  2011-10-11       Impact factor: 3.575

3.  Avoidance disruptive effect of clozapine and olanzapine is potentiated by increasing the test trials: further test of the motivational salience hypothesis.

Authors:  Min Feng; Nan Sui; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2012-09-28       Impact factor: 3.533

4.  Reinforcer magnitude and rate dependency: evaluation of resistance-to-change mechanisms.

Authors:  Jonathan W Pinkston; Brett C Ginsburg; Richard J Lamb
Journal:  Behav Pharmacol       Date:  2014-10       Impact factor: 2.293

5.  Olanzapine and risperidone disrupt conditioned avoidance responding by selectively weakening motivational salience of conditioned stimulus: further evidence.

Authors:  Chen Zhang; Yiru Fang; Ming Li
Journal:  Pharmacol Biochem Behav       Date:  2010-12-29       Impact factor: 3.533

6.  Time course of the attenuation effect of repeated antipsychotic treatment on prepulse inhibition disruption induced by repeated phencyclidine treatment.

Authors:  Ming Li; Erik He; Nick Volf
Journal:  Pharmacol Biochem Behav       Date:  2011-03-21       Impact factor: 3.533

7.  Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.

Authors:  Ming Li; Wei He; Alexa Mead
Journal:  Behav Pharmacol       Date:  2009-02       Impact factor: 2.293

8.  Joseph v. Brady: synthesis reunites what analysis has divided.

Authors:  Travis Thompson
Journal:  Behav Anal       Date:  2012

Review 9.  Cell-type and projection-specific dopaminergic encoding of aversive stimuli in addiction.

Authors:  Kimberly C Thibeault; Munir Gunes Kutlu; Christina Sanders; Erin S Calipari
Journal:  Brain Res       Date:  2018-12-20       Impact factor: 3.252

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.